Biotechnology company Anitoa Systems has launched the Anitoa MAx16, an automation-ready real-time polymerase chain reaction (qPCR) modular system.

The new fully integrated four-plex (4 independent fluorescence channels) qPCR module with 16-well capacity can be easily incorporated into a molecular testing automation flow.

It is suitable for use in various applications, including sample/library preparation for DNA sequencing, integrated sample extraction to amplification and detection nucleic acid test system.

The system includes a fast thermal cycler that can run a complete RT-PCR protocol within 30 minutes.

MAx16 instruments feature Anitoa's in-house manufactured CMOS-based 4-6 channel fluorescence detection optical system.

The system utilises an electrically actuated heat lid to facilitate automation. It also offers a digital interface to the main automation system controller and is compatible with various communication protocols, including qPCR control over a USB link or CAN bus.

Measuring 250mm x 160mm x 140mm and weighing less than 2,200g, MAx16 can be easily integrated into a compact desktop robotic fluid handling automation system.

Anitoa Systems CEO Dr Zhimin Ding said: “We are seeing a growing demand for fully automated molecular test systems that are compact, easy to use and reliable.

“We are excited to participate in this market, and help improve molecular lab test volume and throughput and, at the same time, reduce staff workload.”

In June 2022, the company introduced a CE-marked turn-key PCR testing solution for Monkeypox.

The portable solution comprises a small-footprint real-time PCR instrument known as the Maverick qPCR.

It also features an extraction-free multiplex PCR reagent designed to test OPXV/MPXV gene targets in skin lesion samples from patients suspected of Monkeypox infection.

In May 2022, Anitoa Systems introduced a portable RT-PCR molecular test that can identify dengue virus infections. The solution includes a one-step multiplex RT-PCR reagent in lyophilised format.